A federal appeals court upheld a CRISPR patent awarded to the Cambridge, Mass.-based Broad Institute in a unanimous decision Sept. 10, STAT reports. The decision may mark the end of a yearslong legal ...
The Broad Institute of MIT and Harvard is perhaps best known for the trailblazing work coming out of the labs of its core members; CRISPR tools like David Liu’s prime and base editors, Feng Zhang’s ...
The Regents of the University of California v. The Broad Institute, Inc., Appeal Nos. 2022-1594, -1653 (Fed. Cir. May 12, 2025) Must an inventor know their invention will work to demonstrate that they ...
NVIDIA announced this week a new partnership with Harvard and MIT's Broad Institute, bringing advanced analytics tools to the institute's Terra cloud platform and the more than 25,000 life science ...
This past Thursday, the Board of Appeals of the European Patent Office released the minutes of oral proceedings in which the Board rendered a decision in closely watched appeals relating to Broad ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat cancer, today announced that the company ...
Cambridge, Mass.-based Broad Institute of MIT and Harvard developed a more precise version of the gene-editing tool CRISPR-Cas9, according to the MIT Technology Review. Here are four things to know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results